Sg3 Management, LLC Teva Pharmaceutical Industries LTD Call Options Transaction History

Sg3 Management, LLC

11 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$7.38 - $10.4 $675,270 - $951,600	-91,500 Reduced 48.03%	99,000 $744,000
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $295,399 - $378,417	40,300 Added 26.83%	190,500 $1.79 Million
Q4 2021 Feb 15, 2022	BUY	$7.9 - $10.19 $831,080 - $1.07 Million	105,200 Added 233.78%	150,200 $1.2 Million
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $167,600 - $203,600	20,000 Added 80.0%	45,000 $438,000
Q2 2021 Aug 16, 2021	BUY	$9.9 - $11.56 $148,500 - $173,400	15,000 Added 150.0%	25,000 $248,000
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $605,283 - $776,111	-70,300 Reduced 87.55%	10,000 $97,000
Q3 2020 Nov 13, 2020	BUY	$8.57 - $12.69 $602,471 - $892,107	70,300 Added 703.0%	80,300 $724,000
Q2 2020 Aug 14, 2020	BUY	$8.12 - $13.12 $81,199 - $131,200	10,000 New	10,000 $123,000
Q2 2017 Jan 25, 2018	SELL	N/A	-9,300 Closed	0 $0
Q1 2017 Feb 26, 2018	BUY	N/A	9,207 Added 9900.0%	9,300 $298,000
Q1 2017 Jan 25, 2018	BUY	N/A	93	93 $0

625

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.